Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder

Prog Clin Biol Res. 1990:350:41-59.

Authors

K H Kurth¹, K Mross, F ten Kate, G Weissglas, P J Carpentier, C G Krueger, J Blom, J M Groen, R D van Caubergh, O van Aubel, et al.

Affiliation

¹ Dept. of Urology, University of Amsterdam, The Netherlands.

PMID: 2385609

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Intravesical
Biopsy
Carcinoma in Situ / drug therapy*
Carcinoma in Situ / pathology
Carcinoma in Situ / surgery
Combined Modality Therapy
Drug Evaluation
Epirubicin / administration & dosage*
Epirubicin / adverse effects
Epirubicin / pharmacokinetics
Humans
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / pathology
Urinary Bladder Neoplasms / surgery

Substances

Epirubicin